US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (194)
  • Diseases & Conditions (3439)
  • Drug Delivery (184)
  • Therapeutic Area (5584)
  • Vaccines (630)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Business Strategy: Disruptive Innovation — Transformational Change Coming in Life Science R&D
10/6/2014 | published by: IDC
... operational efficiency and excellence a continuing mantra driving near-term organizational investments, there are few remaining incremental improvements that can deliver the level of cost savings and improved productivity that companies are looking for. While likely ...  |  read more...
USD 4,500
Pharmaceutical Manufacturers & Distributors (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... both a written and graphical analysis – analysing the 430 largest Pharmaceutical Manufacturers & Distributors (UK) companies. The Pharmaceutical Manufacturers & Distributors (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to ...  |  read more...
USD 560
Contract Research (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 130 largest Contract Research (Global) companies. The Contract Research (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section ...  |  read more...
USD 1,520
Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook
10/23/2014 | published by: Timetric
... for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry ...  |  read more...
USD 500
Physician Views: Can Portola's reversal agent act as growth catalyst for novel anticoagulants?
10/8/2014 | published by: FirstWord
... patients who have received therapy with a Factor Xa inhibitor, but whom subsequently need the anticoagulant action to be reversed due to bleeding or the requirement for surgery. Portola's assertion that andexanet alfa will meet ...  |  read more...
USD 645
Medical Logistics (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 40 largest Medical Logistics (UK) companies. The Medical Logistics (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Clinical Research Organization (Nordic) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 80 largest Clinical Research Organization (Nordic) companies. The Clinical Research Organization (Nordic) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. ...  |  read more...
USD 1,000
Pharmaceuticals and Healthcare Report - South Africa Q4 2014
10/8/2014 | published by: Business Monitor International
... investment is increasingly subduedand therefore catalysts for economic development are withdrawing. This will weigh on the pharmaceuticalmarket's development. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.28bn (USD3.45bn) in 2014; +9.6% inlocal currency terms ...  |  read more...
USD 1,295
Basic Pharmaceutical Product Manufacturing in the UK - Industry Market Research Report
10/8/2014 | published by: IBISWorld
... acids and aspirin. The industry also includes companies that process blood and glands and manufacture chemically pure sugars. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and ...  |  read more...
USD 875
U.S. Pharmaceutical Preparation Mfg.. Industry-Industry & Market Report - 2015
10/5/2014 | published by: Barnes Reports
... size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical trends on industry ...  |  read more...
USD 149
Pharmaceuticals and Healthcare Report - Chile Q4 2014
10/15/2014 | published by: Business Monitor International
... drugmakers' strongLatin American presence will continue to attract multinational investment in the country. Headline Expenditure Projections Pharmaceuticals: CLP1,724bn (USD3.5bn) in 2013 to CLP1,849bn (USD3.29bn) in 2014; +7.3% inlocal currency terms and -5.4% in US dollar ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Ghana Q4 2014
10/15/2014 | published by: Business Monitor International
... market due to the increasing popularity of the National Health Insurance Scheme and the government'sgreater emphasis on the pharmaceutical sector and initiatives to combat the presence of counterfeitmedicines. Headline Expenditure Projections Pharmaceuticals: GHS859mn (USD416mn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - India Q4 2014
10/15/2014 | published by: Business Monitor International
... We maintain that the government needs to increase spending onhealthcare rather than pushing costs onto the pharmaceutical industry. Headline Expenditure Projections Pharmaceuticals: INR904.0bn (USD15.4bn) in 2013 to INR1,021.8bn (USD17.6bn) in 2014; +13.0% inlocal currency terms ...  |  read more...
USD 1,295
Bioscience (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Enteral Feeding (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 20 largest Enteral Feeding (UK) companies. The Enteral Feeding (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 190 largest Legionella Control (UK) companies. The Legionella Control (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Mental Health Centres (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 90 largest Mental Health Centres (UK) companies. The Mental Health Centres (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and ...  |  read more...
USD 560
Dermatologicals in Uzbekistan
10/16/2014 | published by: Euromonitor International
... being seen in the channel in 2013 alone. Many new chemists/pharmacies meanwhile opened in underserved areas, with rural areas seeing particularly strong development. A growing focus on consumer service within chemists/pharmacies furthermore resulted in more ...  |  read more...
USD 900
Digestive Remedies in Uzbekistan
10/16/2014 | published by: Euromonitor International
... more consumers to afford OTC digestive remedies. Many consumers also traded up from unpackaged remedies purchased from tabibs (traditional healers) in search of greater quality and efficacy. Euromonitor International's Digestive Remedies in Uzbekistan report offers ...  |  read more...
USD 900
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
... would prescribe them, and the factors likely to affect their future positioning and competitiveness. The recent US approval of Merck's PD-1 inhibitor Keytruda (pembrolizumab) and the expected approval of BMS' Opdivo (nivolumab) are ushering in ...  |  read more...
USD 6,495
Analgesics in Uzbekistan
10/16/2014 | published by: Euromonitor International
... analgesics, while mid-income consumers traded up to the leading brands. Growth was also supported by a population explosion during the review period, expanding the potential consumer base for these products. Euromonitor International's Analgesics in Uzbekistan ...  |  read more...
USD 900
Registered Online Pharmacies (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 100 largest Registered Online Pharmacies (UK) companies. The Registered Online Pharmacies (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and ...  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... the 120 largest Biotechnology (UK) companies. The Biotechnology (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,520
Chemists & Pharmacies (European) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 170 largest Chemists & Pharmacies (European) companies. The Chemists & Pharmacies (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. ...  |  read more...
USD 1,280
Medical & Scientific Research (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (Global) companies. The Medical & Scientific Research (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,520
< prev 1    3  4  5  6  7  8  9  10